| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/07/2005 | EP1570081A2 Amplified genes involved in cancer |
| 09/07/2005 | EP1570075A2 Method for determing predisposition to manifestation of immune system related diseases |
| 09/07/2005 | EP1570069A2 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/07/2005 | EP1570061A2 Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide |
| 09/07/2005 | EP1570057A2 Autocrine growth factor receptor antibodies and methods |
| 09/07/2005 | EP1570055A2 23565, a novel human zinc carboxypeptidase family member and uses thereof |
| 09/07/2005 | EP1570045A2 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 09/07/2005 | EP1569960A2 Recombinant cell line |
| 09/07/2005 | EP1569956A2 Glycogen synthase kinase-3 inhibitors |
| 09/07/2005 | EP1569954A1 Cyanomethyl derivatives as cysteine protease inhibitors |
| 09/07/2005 | EP1569953A1 Peptide gap junction modulators |
| 09/07/2005 | EP1569903A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 09/07/2005 | EP1569895A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 09/07/2005 | EP1569695A2 Antisense modulation of apolipoprotein b expression |
| 09/07/2005 | EP1569689A2 Combination il2/anti-her2-antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
| 09/07/2005 | EP1569686A2 Transmucosal administration of aggregated antigens |
| 09/07/2005 | EP1569685A2 Complement receptor 2 targeted complement modulators |
| 09/07/2005 | EP1569684A2 Use of hmgb fragments as anti-inflammatory agents |
| 09/07/2005 | EP1569682A2 Combination treatment using exendin-4 and thiazolidinediones |
| 09/07/2005 | EP1569681A1 Freeze-dried interferon-gammad; composition for transpulmonary administration and inhalation system therefor |
| 09/07/2005 | EP1569680A2 Treatment of diabetes |
| 09/07/2005 | EP1569679A1 Chaperonin 10 immunosuppression |
| 09/07/2005 | EP1569678A2 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 09/07/2005 | EP1569677A1 Liposomal composition comprising haptotactic peptides |
| 09/07/2005 | EP1569676A2 Calcitonin drug-oligomer conjugates, and uses thereof |
| 09/07/2005 | EP1569675A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 09/07/2005 | EP1569673A1 Novel exendin agonist formulations and methods of administration thereof |
| 09/07/2005 | EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 09/07/2005 | EP1569656A2 Phosphoantigens for regulating an immune response |
| 09/07/2005 | EP1569626A1 Pharmaceutical porous particles |
| 09/07/2005 | EP1569514A2 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 09/07/2005 | EP1443952A4 A method of reducing mortality and morbidity associated with critical illnesses |
| 09/07/2005 | EP1432432A4 A cancer treatment system |
| 09/07/2005 | EP1390407B1 The lectin-like domain of thrombomodulin and its therapeutic use |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1349922A4 Regulation of target protein activity through modified proteins |
| 09/07/2005 | EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists |
| 09/07/2005 | EP1246642B1 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 09/07/2005 | EP1185283B1 Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection |
| 09/07/2005 | EP1151109B1 Fucosyl transferase gene |
| 09/07/2005 | EP1073456B1 Use of osteoprotegerin for the prevention and treatment of cardiovascular diseases |
| 09/07/2005 | EP1071408B1 Microparticles for drug delivery across mucosa and the blood-brain barrier |
| 09/07/2005 | EP1025237B1 Human checkpoint kinase, hcds1, compositions and methods |
| 09/07/2005 | EP0917537B1 Novel parathyroid hormone-related peptide analogs |
| 09/07/2005 | EP0851030B1 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO |
| 09/07/2005 | EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins |
| 09/07/2005 | CN1665934A GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1, 4)-N-acetylglucosaminyltransferase III) expression in plants |
| 09/07/2005 | CN1665933A Immunoconjugates for the treatment of tumours |
| 09/07/2005 | CN1665932A Vectors with modified protease-dependent tropism |
| 09/07/2005 | CN1665931A Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665927A Tumor-lysing virus growing selectively in tumor cells |
| 09/07/2005 | CN1665925A Factor VII or VIIa polypeptide variants |
| 09/07/2005 | CN1665922A Medium for culturing autologous human progenitor stem cells and applications thereof |
| 09/07/2005 | CN1665839A Novel antagonists of MCP proteins |
| 09/07/2005 | CN1665837A Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 09/07/2005 | CN1665836A Phosphoinositolglycan (PIG)-binding protein from adipocytes |
| 09/07/2005 | CN1665835A DNA sequence and recombinant production of the grass pollen allergen Phl p4 |
| 09/07/2005 | CN1665833A Novel variants of the PapM polypeptide of bacteria of genus streptomyces |
| 09/07/2005 | CN1665565A GHRELIN-carrier conjugates |
| 09/07/2005 | CN1665543A Fusions of cytokines and tumor targeting proteins |
| 09/07/2005 | CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 09/07/2005 | CN1665525A Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665522A Method of up-regulating tumor antigen expression using thymalfasin |
| 09/07/2005 | CN1665515A Methods for treating psychosis associated with interferon-alpha therapy |
| 09/07/2005 | CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 09/07/2005 | CN1665491A Microcapsules for the delayed, controlled release of perindopril |
| 09/07/2005 | CN1665490A 控释组合物 A controlled release composition |
| 09/07/2005 | CN1665488A Direct cellular energy delivery system |
| 09/07/2005 | CN1665487A Liposomal vaccine |
| 09/07/2005 | CN1665404A Satiety inducing composition |
| 09/07/2005 | CN1664100A Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof |
| 09/07/2005 | CN1664097A Expression of Hypoderm A (HA) in pastoris system and use thereof |
| 09/07/2005 | CN1663963A Hybrid interferon compositions and methods of use |
| 09/07/2005 | CN1663959A Beta-glucan peptide and its preparing process and application |
| 09/07/2005 | CN1663610A Lysozyme preparation |
| 09/07/2005 | CN1663609A Eye drop for treating conjunctivitis and keratitis |
| 09/07/2005 | CN1663608A Medicine for treating infantile anorexia |
| 09/07/2005 | CN1663607A Antisenescence medicine |
| 09/07/2005 | CN1663606A Medicine for treating radiation diseases |
| 09/07/2005 | CN1663605A Ear drop for treating chronic tympanitis |
| 09/07/2005 | CN1663604A Spray for treating chronic pharyngitis |
| 09/07/2005 | CN1663603A Applications of tumor-placenta antigen protein and its DNA in tumor treatment |
| 09/07/2005 | CN1218041C Lumbricus kinase of electrophoretical purity and its prepn and use |
| 09/07/2005 | CN1217956C Soluble single-chain T-cell receptor proteins |
| 09/07/2005 | CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 09/07/2005 | CN1217697C Peptide antagonists of zonulin and methods for use of same |
| 09/07/2005 | CN1217650C Oral composition providing enhanced tooth stain removal |
| 09/06/2005 | US6941229 Method of designing agonists and antagonists to EGF receptor family |
| 09/06/2005 | US6939959 Efficient protein expression system |
| 09/06/2005 | US6939948 blocks the binding of an anti-GD2 antibody to a tumor cell expressing GD2 ganglioside; elicit an immune response against a tumor associated antigen that is not normally immunogenic |
| 09/06/2005 | US6939947 administering glycoproteins as antibiotics for prophylaxis of bacterial infections; vancomycin derivatives; peptide antibiotics |
| 09/06/2005 | US6939946 Ring modified cyclic peptide analogs |
| 09/06/2005 | US6939945 Synthetic peptide for use as tool in human therapeutics and diagnostics |
| 09/06/2005 | US6939880 Compounds with growth hormone releasing properties |